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Life course health consequences and associated annual 
costs of adverse childhood experiences across Europe and 
North America: a systematic review and meta-analysis
Mark A Bellis, Karen Hughes, Kat Ford, Gabriela Ramos Rodriguez, Dinesh Sethi, Jonathon Passmore
Summary
Background An increasing number of studies are identifying associations between adverse childhood experiences 
(ACEs) and ill health throughout the life course. We aimed to calculate the proportions of major risk factors for and 
causes of ill health that are attributable to one or multiple types of ACE and the associated financial costs.
Methods In this systematic review and meta-analysis, we searched for studies in which risk data in individuals with 
ACEs were compared with these data in those without ACEs. We searched six electronic databases (MEDLINE, 
CINAHL, PsycINFO, Applied Social Sciences Index and Abstracts, Criminal Justice Databases, and the Education 
Resources Information Center) for quantitative studies published between Jan 1, 1990, and July 11, 2018, that reported 
risks of health-related behaviours and causes of ill health in adults that were associated with cumulative measures of 
ACEs (ie, number of ACEs). We included studies in adults in populations that did not have a high risk of ACEs, that 
had sample sizes of at least 1000 people, and that provided ACE prevalence data. We calculated the pooled RR for risk 
factors (harmful alcohol use, illicit drug use, smoking, and obesity) and causes of ill health (cancer, diabetes, 
cardiovascular disease, respiratory disease, anxiety, and depression) associated with ACEs. RRs were used to estimate 
the population-attributable fractions (PAFs) of risk attributable to ACEs and the disability-adjusted life-years (DALYs)
and financial costs associated with ACEs. This study was prospectively registered in PROSPERO (CRD42018090356).
Findings Of 4387 unique articles found following our initial search, after review of the titles (and abstracts, when the 
title was relevant), we assessed 880 (20%) full-text articles. We considered 221 (25%) full-text articles for inclusion, of 
which 23 (10%) articles met all selection criteria for our meta-analysis. We found a pooled prevalence of 23·5% of 
individuals (95% CI 18·7–28·5) with one ACE and 18·7% (14·7–23·2) with two or more ACEs in Europe (from 
ten studies) and of 23·4% of individuals (22·0–24·8) with one ACE and 35·0% (31·6–38·4) with two or more ACEs 
in north America (from nine studies). Illicit drug use had the highest PAFs associated with ACEs of all the risk factors 
assessed in both regions (34·1% in Europe; 41·1% in north America). In both regions, PAFs of causes of ill health 
were highest for mental illness outcomes: ACEs were attributed to about 30% of cases of anxiety and 40% of cases of 
depression in north America and more than a quarter of both conditions in Europe. Costs of cardiovascular disease 
attributable to ACEs were substantially higher than for most other causes of ill health because of higher DALYs for 
this condition. Total annual costs attributable to ACEs were estimated to be US$581 billion in Europe and $748 billion 
in north America. More than 75% of these costs arose in individuals with two or more ACEs.
Interpretation Millions of adults across Europe and north America live with a legacy of ACEs. Our findings suggest 
that a 10% reduction in ACE prevalence could equate to annual savings of 3 million DALYs or $105 billion. Programmes 
to prevent ACEs and moderate their effects are available. Rebalancing expenditure towards ensuring safe and 
nurturing childhoods would be economically beneficial and relieve pressures on health-care systems.
Funding World Health Organization Regional Office for Europe.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
An increasing number of studies1 have identified the 
long-term effects of adverse childhood experiences 
(ACEs) on health throughout the life course. The term 
ACEs refers to some of the most intense sources of 
stress that children can be exposed to, including child 
maltreatment, interparental violence, and parental 
substance use. Along with immediate health and 
educational effects,2 ACEs have been linked to higher 
risks of health-harming behaviours, including smoking, 
harmful alcohol con- sumption, and drug use.1,3,4 Exposure 
to ACEs is also associated with an increased risk of 
mental illness and other conditions, including cancer 
and cardiovascular disease.1,4,5 The effect of ACEs 
on mental health and adoption of health-harming 
behaviours is one set of mechanisms connecting 
ACEs to chronic ill health.6 However, evidence from 
biomedical studies7 suggests that ACEs also directly 
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affect neurological, hormonal, and immunological 
develop ment. Thus, ACEs are associated with increasing 
biomarkers for inflammation and shortened telomeres, 
which is consistent with direct effects of ACEs on 
chronic diseases such as cancer, cardiovascular disease, 
and respiratory disease.8
Global estimates suggest approximately 1 billion children 
(aged 2–17 years) were victims of violence in the past year.9 
Consequently, the UN Sustainable Development Goals 
include a target (16.2) to end all forms of violence against 
children. Additionally, health ministries in WHO member 
states have committed to a global plan of action, to 
strengthen the role of the health system within a national 
multisectoral response to address interpersonal violence, 
in particular against women and girls and against 
children.10 These commitments are supported by regional 
action plans.11 Although such policy initiatives can focus 
on specific topics (such as child maltreatment), ACEs 
routinely cluster in affected households, with mal- 
treatment, domestic violence, and caregiver mental illness 
or substance abuse often affecting the same children. 
Globally, more than one in four people have a mental 
illness in their lifetime,12 and around one in three women 
who have been in a relationship have been subjected to 
intimate partner violence.13 Many incidents of such 
violence occur in households containing children and, 
although the harmful effects of these experiences on 
children are well established,14 there are no global measures 
of the numbers of children affected.
The effects of ACEs on health-harming behaviours 
or health conditions can be additive or multiplicative, 
resulting in substantially increased risks to those expe- 
riencing multiple types of ACEs.1 Despite the possible 
interaction of these effects, estimates of costs imposed by 
ACEs have, to date, focused on individual ACEs (such as 
child maltreatment)15,16 rather than the combined costs of 
several ACEs. Research exploring such costs is needed to 
highlight the economic and health burden of ACEs and to 
make connections between often disjointed policies that 
tackle child maltreatment, domestic violence, and other 
ACEs separately. To our knowledge, there has been no 
attempt to systematically combine studies to examine the 
proportion of risk factors or causes of ill health that can be 
attributed to one or multiple ACEs. Global, regional, and 
national efforts to ensure safer childhoods, protect 
women, control substance use, and prevent long-term 
effects of ACEs, particularly on non-communicable 
diseases (NCDs), require such knowledge.
We therefore aimed to combine ACE studies from 
Europe and, separately, north America, to calculate the 
PAFs (ie, the proportion of adverse health outcomes 
in the population that are attributable to ACEs) for key 
Research in context
Evidence before this study
An increasing number of studies are examining the 
relationships between exposure to adverse childhood 
experiences (ACEs), such as child maltreatment and exposure 
to domestic violence, and health outcomes across the life 
course. Childhood exposure to an increasing number of 
ACEs has an ordinal relationship with a higher prevalence of 
common health risk factors (such as smoking and obesity) 
and long-term causes of ill health (such as cancers, 
cardiovascular disease, and diabetes) in later life. These effects 
have been demonstrated primarily in high-income countries 
and are supported by studies of ACE-related physiological 
changes consistent with increased health risks. We searched 
six electronic databases (MEDLINE, CINAHL, PsycINFO, Applied 
Social Sciences Index and Abstracts, Criminal Justice Databases, 
and Education Resources Information Center) to identify 
quantitative studies that reported risks of health-related 
behaviours and causes of ill health in adults that were 
associated with cumulative measures of ACEs (ie, number of 
ACEs). We used the search terms “adverse childhood 
experience*”, “adverse childhood event*”, and “childhood 
adversit*”, with no language restrictions. We supplemented 
searches by screening reference lists of retrieved studies and 
through use of research networks (ie, screening online 
resources maintained by active ACE researchers). We searched 
for all relevant studies published between Jan 1, 1990, 
and July 11, 2018.
Added value of this study
With meta-analyses and population-attributable fraction 
methods, we pooled data on ACE-attributable risks for leading 
risk factors for and causes of ill health, and we converted these 
into annual ACE-attributable disability-adjusted life-years 
(DALYs) for Europe and north America. We calculated the 
absolute measures of ill health that could potentially be 
avoidable by preventing ACEs in childhoods across each global 
region. Finally, through a human capital approach, 
we expressed ACE-attributable ill health (in DALYs) 
as annual financial costs. We estimated that the annual 
costs from the effect of ACEs on the health outcomes 
measured were US$581 billion in Europe (equivalent to 
2·67% of gross domestic product) and $748 billion in north 
America (equivalent to 3·55% of gross domestic product).
Implications of all the available evidence
Despite growing epidemiological and physiological evidence, 
the effect of ACEs on national and international health policy 
has been slow to emerge. Our findings suggest that ACEs are 
consistently an avoidable risk factor for some of the largest 
threats to public health and costs to health services across 
Europe and north America. Evidence-based approaches to 
preventing ACEs and moderating their effects are available. 
The implementation of these approaches at scale could provide 
millions more individuals with better quality childhoods and 
generate substantial cost savings.
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health-harming behavioural risk factors (such as smoking) 
and causes of ill health (such as diabetes). We present 
PAFs associated with exposure to one or multiple ACEs, 
and we used the 2017 Global Burden of Disease (GBD) 
Study to calculate ACE-related disability-adjusted life years 
(DALYs) for each risk factor and cause. Finally, we used a 
human capital model15 to provide a financial estimate of 
the annual costs of ACEs to Europe and north America.
Methods
Search strategy and selection criteria
In this systematic review and meta-analysis, we searched 
for studies in which risk data in individuals with ACEs 
were compared with risk data in those without ACEs. We 
included studies that were predominantly focused on 
adults and populations that were not at a known high risk 
of ACEs; that had sample sizes of at least 1000 people; that 
provided prevalence data for the number of ACEs 
experienced (ACE count); and that presented the odds ratio 
(OR), relative risk (RR), or hazard ratio (HR) for one ACE 
and multiple ACEs (in any ACE count categories, 
permitting synthesis into categories of one and at least two 
ACEs). To be included, studies were required to have 
measured at least three types of ACE.
We searched six electronic databases (MEDLINE, 
CINAHL, PsycINFO, Applied Social Sciences Index and 
Abstracts, Criminal Justice Databases, and the Education 
Resources Information Center) to identify quantitative 
studies that reported risks of health-related behaviours and 
causes of ill health in adults that were associated with 
cumulative measures of ACEs (ie, number of ACEs). We 
used the search terms “adverse childhood experience*”, 
“adverse childhood event*”, and “childhood adversit*”, 
with no language restrictions. We supplemented searches 
by screening reference lists of retrieved studies and 
through use of research networks (ie, screening online 
resources maintained by active ACE researchers). KH did 
a search for all relevant studies published between 
Jan 1, 1990, and Dec 6, 2017. This search was updated on 
July 11, 2018. KH and GRR independently screened titles 
and abstracts, then full texts of articles that were judged to 
be relevant.
We included studies that reported summary estimates at 
population levels of relationships between cumulative 
ACEs and any of four risk factors (harmful alcohol use, 
illicit drug use, smoking, or obesity) or six causes of ill 
health (cancer, diabetes, cardiovascular disease, respiratory 
disease, anxiety, or depression).
Data analysis
KH, KF, and GRR extracted data from included studies on 
country, study type, number of participants, population 
surveyed, and ACE and outcome measurements. We 
identified the outcomes and geographical coverage of 
studies by considering the number of studies available, 
outcomes measured, and the availability of data on DALYs 
associated with risks or causes of ill health within the GBD 
study. Thus, we included studies that were done in two 
global regions: Europe (WHO European Region) and 
north America (World Bank region; appendix p 1); and 
those that reported relationships between cumulative 
ACEs and any of the four risk factors or six causes of ill 
health.
Where more than one study reported data from the same 
sample and outcome, only one study was selected, which 
we based on a larger sample size or better suitability of 
data. Where several study outcomes could contribute to a 
single health condition, two reviewers (KH and GRR) 
independently identified the best match, with a third 
reviewer (MAB) resolving any conflicts. We did not use any 
specific outcome definitions, but individual study criteria 
are shown in the appendix (p 1).
RRs, HRs, or ORs were extracted at each available 
ACE count level (adjusted for demographics and 
socioeconomic status where available; table 1).3–5,17–36 All 
articles reported some sociodemographic adjustments and 
adjusted ORs were transformed into RRs by use of the 
equation: RR=OR/(1 − p0+ [p0 × OR]), where po is the 
baseline risk in the absence of ACEs.37 Adjusted positive 
and negative counts by condition and ACE category were 
also generated for use in the meta-analysis. Covariates 
from proportional hazards models were treated as RRs. 
For each study, all categories of RR for more than one ACE 
were combined to give an RR for two or more ACEs by use 
of a weighted mean method with weighting by proportions 
in each ACE category. Pooled RRs with 95% CIs for each 
risk factor and cause in each region were generated 
through random effects models. Where there was only one 
study, the RR was calculated directly from that study. We 
calculated pooled prevalence of individuals with one ACE 
and with two or more ACEs for each region with the 
Stuart–Ord method, and we calculated pooled RRs with 
the DerSimonian and Laird method (which we used to fit 
random effects). Both methods generated CIs for pooled 
and individual studies.
Heterogeneity between studies was measured with the 
I² statistic.38 The risk of publication bias was evaluated by 
use of the Begg and Mazumdar and Egger tests and visual 
inspection of funnel plots where sufficient studies (more 
than ten)38 were available (appendix).
For each health outcome, we calculated population-
attributable fractions (PAFs) for each ACE exposure level 
(ie, one ACE or at least two ACEs) by use of the equations:
and
For the Institute for Health 
Metrics and Evaluation Global 




PACE1 × (RRACE1 – 1)
(PACE0) + (PACE1 × RRACE1) + (PACE2+ × RRACE2+)
See Online for appendix
PAFACE2+=
PACE2+ × (RRACE2+ – 1)
(PACE0) + (PACE1 × RRACE1) + (PACE2+ × RRACE2+)
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where RRACE(exposure) is the pooled RR associated with ACEs 
and PACE(exposure) the proportion of the sample exposed to a 
particular ACE count level.39 The benefits and limitations 
of PAF methods are discussed elsewhere.40
To calculate costs associated with each risk factor and 
cause, we adapted the human capital method.15,41 Human 
capital methods assign a monetary value to loss of health, 
which is calculated as reduced economic productivity 
due to ill health and premature mortality. We identified a 
matched category in the GBD study dataset for each risk 
factor and cause (appendix). We extracted estimates of 
DALYs in 2017 for each region for the age categories 
15–49 years, 50–69 years, and older than 70 years. Gross 
domestic product (GDP) and GDP per capita (2017 
current US$) were extracted from World Bank data for 
north America (region) and Europe (extracted for each 
country and combined). Following the human capital 
method, we assume one DALY is equal to a region’s GDP 
per capita, thus costs for each condition are calculated 
based on the number of DALYs × GDP per capita. PAFs 
were applied to total cost to estimate the regional 
economic value of DALYs lost for each risk factor and 
cause by ACE level (ie, one ACE or two or more ACEs). 
We also calculated the value of DALYs lost as a percentage 
of total regional GDP. To generate a total cost of ACEs, 
we removed DALYs from risk factors that also related to 
specified causes, to avoid counting twice (eg, we did not 
count the DALYs related to smoking that were also 
attributed to cancer).
In prespecified sensitivity analyses, we calculated 
DALYs and associated costs with upper and lower CIs for 
pooled RRs and ACE prevalence and, in another analysis, 
we also restricted DALYs to those for individuals aged 
15–69 years. Data editing and calculations were done 
in Excel. We used StatsDirect (version 3.1.18) for meta-
analyses. This study was prospectively registered in 
PROSPERO (CRD42018090356).
Role of the funding source
The funder of the study contributed to study design and 
writing of the report. The funder of the study had no role 
in data collection, data analysis, or data interpretation. 
The corresponding author had full access to all the data 
in the study and had final responsibility for the decision 
to submit for publication.
Results
We retrieved 9156 articles in our initial search (figure 1). 
After we removed duplicates (leaving 4387 [48%] unique 
references) and reviewed the titles (and abstracts, when 
the title was relevant), we assessed the 880 (10%) full 
texts that remained. We excluded 3507 (38%) articles 
after the title and abstract review, and we excluded 659 (7%) 
articles after full text review. We considered 221 (25%) 
full-text articles for inclusion. We excluded 200 (90%) of 
these articles because they did not include outcomes 
used in our meta-analysis (n=74), they did not specify the 
necessary data (n=33), the sample size was too low 
(n=29), they duplicated data from other studies (n=28), 
they used inappropriate methods (n=24), or they had 
inappropriate study populations (n=7; ie, sample was 
known to be at high risk of ACEs) or geography (n=5). 
23 (10%) articles met all selection criteria for our meta-
analysis.
The characteristics of the 23 articles in our meta-
analysis are shown in table 1.3–5,17–36 11 studies were based 
in Europe and 12 studies were in north America 
(predominantly the USA). Sample sizes ranged from 
1500 to 978 647 people. The two largest studies20,22 used 
whole-population birth cohorts. Most other studies 
used representative general population samples, but 
three studies used a health insurance sample,17,23,25 
two used primary care samples,32,34 and one used higher 
education samples.19 There was variation in number and 
type of ACEs measured, but most studies covered a 
similar core set of ACEs (appendix p 2). These ACEs 
included child physical, sexual, and emotional abuse; 
exposure to domestic violence; parental separation; and 
For The World Bank World 
Development Indicators see 
http://databank.worldbank.org/
data/home
Figure 1: Study selection flowchart
ACE=adverse childhood experience. *Did not meet study requirements.
9156 articles retrieved for 
title and abstract review
2 additional studies identified from 
manual searches of reference lists 
and research 
880 full texts assessed for 
eligibility
221 articles considered for 
inclusion 
4387 unique references 
screened in title and 
abstract review
23 articles included in the 
meta-analysis
200 excluded
74 did not include outcomes used in the 
      meta-analysis 
33 did not have the required data available 
29 because the sample size was too low
28 duplicated data from other studies
24 had inappropriate ACE or outcome 
measurement 
7 because of an inappropriate sample 
(known to be at high risk of ACEs) 
5 because of inappropriate geography 
(outside of Europe and north America)
659 excluded
552 with no relevant or accessible ACE or
         outcome data
81 used an inappropriate sample
26 were reviews
3507 excluded 
3500 were reviews or case reports, used an
            inappropriate sample, or reported
            no relevant ACE or outcome
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household member substance abuse, mental illness, and 
criminality.
Pooled RRs for risk factors and causes of ill health are 
shown in table 2. Forest plots of these data are shown in 
the appendix (p 9). Across all risk factors in both regions, 
pooled RRs (reference category 0 ACEs) increased more 
when exposed to two or more ACEs compared with one 
ACE. In both regions, the highest RRs were for illicit 
drug use (but, for north America, this RR was based on 
a single study), followed by harmful alcohol use, 
smoking, then obesity. In Europe, the lower CIs for 
obesity risk estimates included an RR value of 1 with one 
and two or more ACEs. There was considerable 
heterogeneity between estimates for alcohol use in both 
regions. Heterogeneity between estimates for smoking 
and obesity was also notably high in north American 
studies.
For all causes of ill health, RRs were higher with two 
or more ACEs than with one ACE. With one ACE, lower 
CIs included an RR value of 1 in both regions for 
cancer; in Europe, for diabetes and cardiovascular 
disease; and, in north America, for anxiety. The highest 
pooled RR associated with ACEs was reported for 
depression in both regions. With two or more ACEs, we 
found that the lowest RR was for diabetes in both 
regions, and the highest RR was for depression and 
anxiety. However, there was considerable heterogeneity 
between most estimates for both mental illness 
outcomes (where calculable). Heterogeneity between 
estimates was low to moderate for all physical health 
conditions with one ACE, and for cancer with two or 
more ACEs. There was substantial heterogeneity 
between estimates for other conditions with two or 
more ACEs.
Studies (n)* Individuals (n) 1 ACE ≥2 ACEs
Pooled relative risk Heterogeneity, I² Pooled relative risk Heterogeneity, I²
Risk factors
Harmful alcohol use
Europe 4 20 427 1·51 (1·22–1·87) 75·4% (0–89·1) 2·11 (1·13–3·95) 98·0% (97·1–98·5)
North America 5 85 745 1·44 (1·20–1·74) 80·1% (37·6–89·8) 1·81 (1·22–2·68) 96·7% (95·2–97·6)
Illicit drug use
Europe 4 21 365 1·69 (1·48–1·93) 45·7% (0–80·7) 2·89 (2·68–3·12) 0% (0–67·9)
North America 1 17 337 1·53 (1·36–1·72) NA 2·64 (2·40–2·91) NA
Smoking
Europe 4 21 402 1·29 (1·21–1·38) 1% (0–68·2) 1·82 (1·71–1·95) 25·9% (0–75·5)
North America 7 113 339 1·23 (1·04–1·46) 93·1% (88·9–95·2) 1·74 (1·47–2·05) 95·1% (92·8–96·4)
Obesity
Europe 2 6437 1·06 (0·99–1·15) 0%† 1·24 (0·85–1·79) 41·2%†
North America 5 78 004 1·08 (1·00–1·17) 69·9% (0–86·2) 1·23 (1·06–1·43) 93·8% (89·1–95·9)
Causes of ill health
Anxiety
Europe 1 2493 1·44 (1·17–1·77) NA 2·56 (2·19–2·98) NA
North America 3 30 859 1·08 (0·66–1·77) 94% (85·6–96·6) 2·25 (1·43–3·56) 96·1% (92·5–97·6)
Depression
Europe 3 1 459 284 1·54 (1·51–1·57) 0% (0–72·9) 2·34 (2·19–2·50) 82·5% (0–92·5)
North America 7 91 112 1·34 (1·15–1·56) 88·6% (78·5–92·8) 2·69 (2·17–3·33) 96·8% (95·6–97·5)
Cancer
Europe 4 21 593 1·08 (0·89–1·30) 39·6% (0–79·1) 1·58 (1·32–1·91) 25·6% (0–75·4)
North America 2 14 372 1·10 (0·95–1·28) 0%† 1·25 (1·10–1·43) 0%†
Cardiovascular disease
Europe 3 15 742 1·11 (0·99–1·24) 0% (0–72·9) 1·57 (1·20–2·06) 59·9% (0–86·7)
North America 6 83 932 1·16 (1·04–1·29) 55·2% (0–80) 1·60 (1·41–1·81) 75·7% (26·9–87·4)
Diabetes
Europe 3 15 733 1·02 (0·88–1·19) 0% (0–72·9) 1·43 (1·11–1·83) 58·7% (0–86·4)
North America 6 74 662 1·11 (1·02–1·22) 39·3% (0–74·7) 1·15 (0·97–1·37) 85·3% (66·5–91·5)
Respiratory disease
Europe 5 38 075 1·19 (1·04–1·35) 14·7% (0–69·1) 1·98 (1·42–2·76) 83·3% (53·1–91·1)
North America 5 67 417 1·29 (1·17–1·41) 0% (0–64·1) 1·90 (1·58–2·29) 77% (19·4–88·6)
Data in parentheses are 95% CIs. ACE=Adverse childhood experience. NA=not applicable. *Included studies are shown in the appendix (p 9). †CIs not calculable.
Table 2: Pooled relative risks for risk factors and causes of ill health
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We calculated regional estimates of ACE prevalence by 
pooling prevalence data across studies (excluding duplicate 
samples). Ten studies (comprising 1 514 254 individuals) in 
Europe provided a pooled prevalence of 23·5% of these 
individuals (95% CI 18·7–28·5) with one ACE and 18·7% 
(14·7–23·2) with two or more ACEs (appendix p 6). Nine 
studies (comprising 121 341 individuals) in north America 
provided a pooled prevalence of 23·4% (22·0–24·8) with 
one ACE and 35·0% (31·6–38·4) with two or more ACEs. 
There was high heterogeneity between estimates in both 
regions (appendix p 6). These regional ACE prevalence 
estimates were used in PAF and costs calculations.
Illicit drug use had the highest PAFs associated with 
ACEs of all the risk factors assessed in both regions 
(34·1% in Europe; 41·1% in north America, based on a 
single study), with estimated ACE-related annual costs 
of $46 billion in Europe and $168 billion in north 
America (table 3). Approximately a quarter of harmful 
alcohol use was associated with ACEs in both regions. 
Because of substantially higher DALYs associated with 
alcohol use than with drug use in Europe, the estimated 
ACE-attributable costs of alcohol use were more than 
three times higher than for drugs, reaching $143 billion 
(0·65% of GDP). Conversely, in north America, DALYs 
associated with alcohol use ($73 billion; 0·34% of GDP) 
were lower than those with drugs, meaning that ACE-
attributable costs were also lower. ACEs were attributed 




for risk factor 
(thousands)*







Total attributable costs by 
ACE count (billion US$)†
Total 
attributable 
costs of ACEs 
(% of GDP)
1 ACE ≥2 ACEs All ACEs 1 ACE ≥2 ACEs All ACEs 1 ACE ≥2 ACEs All ACEs
Risk factors
Harmful alcohol use
Europe 9·1% 15·6% 24·7% 24 478 2217 3825 6042 577 52 90 143 0·65%
North America 7·5% 20·4% 27·9% 4474 335 915 1250 260 19 53 73 0·34%
Illicit drug use
Europe 10·7% 23·4% 34·1% 5702 610 1333 1944 135 14 31 46 0·21%
North America‡ 7·3% 33·8% 41·1% 7059 514 2385 2899 410 30 138 168 0·80%
Smoking
Europe 5·6% 12·6% 18·2% 38 541 2142 4873 7015 909 51 115 165 0·76%
North America 4·1% 19·6% 23·7% 11 595 479 2274 2753 673 28 132 160 0·76%
Obesity
Europe 1·4% 4·2% 5·6% 30 072 430 1251 1681 709 10 30 40 0·18%
North America 1·7% 7·3% 9·0% 12 542 207 917 1124 728 12 53 65 0·31%
Causes of ill health
Anxiety
Europe‡ 7·4% 20·9% 28·3% 3410 252 714 966 80 6 17 23 0·10%
North America 1·2% 30·1% 31·3% 1986 25 597 622 115 1 35 36 0·17%
Depression
Europe 9·2% 18·3% 27·5% 4417 406 807 1213 104 10 19 29 0·13%
North America 4·8% 35·3% 40·1% 1990 95 703 798 116 6 41 46 0·22%
Cancer
Europe 1·6% 9·7% 11·3% 43 828 716 4258 4974 1034 17 100 117 0·54%
North America‡ 2·2% 7·9% 10·1% 16 277 351 1290 1641 945 20 75 95 0·45%
Cardiovascular disease
Europe 2·2% 9·5% 11·7% 67 115 1492 6357 7848 1583 35 150 185 0·85%
North America 2·9% 16·8% 19·7% 16 849 496 2825 3321 978 29 164 193 0·92%
Diabetes
Europe 0·5% 7·4% 7·9% 8602 41 636 677 203 1 15 16 0·07%
North America 2·5% 5·0% 7·5% 4195 104 209 313 244 6 12 18 0·09%
Respiratory disease
Europe 3·6% 14·9% 18·5% 10 657 383 1591 1974 251 9 38 47 0·21%
North America 4·8% 22·8% 27·6% 6176 298 1410 1707 359 17 82 99 0·47%
ACE=Adverse childhood experience. GDP=gross domestic product. *Rounded to the nearest thousand. †Rounded to the nearest billion, 2017 GDP. ‡Based on a single study.
Table 3: Population-attributable fractions and DALYs and costs attributable to ACEs for risk factors and causes of ill health
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in north America, with estimated associated costs of 
$165 billion (Europe) and $160 billion (north America). 
Although PAFs of obesity associated with ACEs were 
low compared with other risk factors, ACE-attributable 
costs were $40 billion in Europe and $65 billion in north 
America.
In both regions, PAFs of causes of ill health were highest 
for mental illness outcomes (table 3). ACEs were attributed 
to about 30% of anxiety cases and 40% of depression cases 
in north America and more than a quarter of both 
conditions in Europe. The combined annual costs of 
depression and anxiety attributed to ACEs were around 
$51 billion in Europe and $82 billion in north America. 
More than a quarter of cases of respiratory disease in 
north America and about one-fifth of cases in Europe 
were attributed to ACEs, with estimated costs of $99 billion 
(north America) and $47 billion (Europe). PAFs of 
cardiovascular disease and cancer to ACEs were lower 
than for most other causes of ill health, yet associated 
costs were substantially higher because of higher DALYs 
for these conditions. Diabetes had the lowest PAFs to 
ACEs of causes studied.
In both regions, most ACE-attributable costs were 
accounted for by exposure to two or more ACEs (vs 
one ACE; table 3). The proportions of costs accounted 
for by individuals with two or more ACEs ranged from 
63% for alcohol use in Europe ($90 billion, of a total 
ACE-attributable cost of $143 billion) to 96% for anxiety 
in north America ($35 billion of $36 billion). Total 
annual costs attributable to ACEs were estimated to be 
$581 billion in Europe (equivalent to 2·67% of GDP) and 
$748 billion in north America (equivalent to 3·55% of 
GDP). In Europe, 77% of these costs arose in individuals 
with two or more ACEs whereas, in north America, this 
value was 82%. A 10% reduction in ACE prevalence (to 
values of 21·1% with one ACE and 16·9% with two or 
more ACEs in Europe; and 21·0% with one ACE and 
31·5% with two or more ACEs in north America) would 
result in a corresponding reduction of 3 million DALYs 
(approximately 2 million in Europe and 1 million 
in north America) equivalent to annual savings of 
$105 billion ($49 billion in Europe, $56 billion in north 
America).
In sensitivity analyses, we also generated regional PAFs 
for each outcome by use of upper and lower 95% CIs for 
pooled RRs and ACE prevalence (figure 2; appendix p 4). 
After excluding duplicated DALYs, we estimated total 
annual costs from ACEs for the lowest costed model at 
$233 billion for Europe (equivalent to 1·07% of regional 
GDP) and $448 billion for north America (2·13% of 
GDP); and, for the highest costed model, at $938 billion 
for Europe (4·31% regional GDP) and more than 
$1 trillion for north America (4·90% of GDP).
A sensitivity analysis in which we excluded the four 
samples that were not from the general population 
showed variable effects on PAFs by risk factor and cause 
(appendix p 4). A final sensitivity analysis restricted DALYs 
to those experienced by individuals aged 15–69 years. 
Because many long-term conditions affect individuals 
older than 70 years, this adjustment resulted in a 
substantive effect on estimates, reducing total DALYs 
attributable to ACEs by 32·1% in Europe and 27·8% in 
Figure 2: Sensitivity analyses of combined ACE-attributable DALYs and costs relating to risk factors and causes of ill health
(A) ACE-attributable DALYs. (B) ACE-attributable costs. DALYs for risk factors (harmful alcohol use, illicit drug use, smoking, and obesity) exclude those attributed to 









































Based on PAFs generated with upper CIs for pooled relative risks
Based on PAFs generated with upper CIs for pooled prevalence of ACEs
Best estimate: people aged 15 years and older, pooled relative risks, pooled ACE prevalence
Based on PAFs generated using lower CIs for pooled prevalence of ACEs
Limited to DALYs for people aged 15–69 years
Based on PAFs generated with lower CIs for pooled relative risks
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north America, and decreasing estimated costs to 
$394 billion in Europe and $540 billion in north America.
Discussion
Several studies1 have examined how ACEs relate to the 
adoption of health-harming behaviours and development 
of ill health. We combined such studies to estimate 
the annual health and financial costs accrued because 
of ACEs. These costs appear substantive, totalling 
37·5 million DALYs and $1·3 trillion per annum across 
north America and Europe for four risk factors and 
six causes of ill health. We also examined costs associated 
with experiencing multiple ACEs compared with just one. 
Across all outcomes, experience of two or more ACEs 
resulted in higher RRs of risk factors and causes of ill 
health and accounted for a greater proportion of DALYs 
and costs than one ACE. Reducing such costs requires 
work that connects child maltreatment, domestic violence, 
caregiver mental illness, and other sources of childhood 
trauma. However, these issues have traditionally been 
addressed and economically assessed separately.11
Our findings support a strong relationship between 
ACEs and conditions relating to mental health. PAFs 
associated with ACEs for depression, anxiety, and illicit 
drug use ranged from 27·5% to 41·1%. The burden of 
disease related to mental illness is growing globally,42 
and our findings reinforce previous results that 
identify childhood as a crucial time in establishing the 
foundations of good mental health.43 Although NCDs had 
lower PAFs to ACEs than mental health conditions 
(ranging from 7·5% to 27·6%; table 3), they nevertheless 
reflect huge, ongoing, and avoidable costs to the health 
and economies of both regions. ACE-related cancer, 
cardiovascular disease, respiratory disease, and diabetes 
together accounted for an estimated annual 15·5 million 
DALYs in Europe and 7 million DALYs in north America. 
Studies25 linking ACEs to NCDs have been available for 
more than two decades. However, global efforts to 
tackle risk factors for NCDs have typically focused on 
addressing alcohol, tobacco, and food consumption 
directly rather than childhood stressors that might leave 
individuals vulnerable to harmful consumption of 
such items. Our study has identified that potentially 
319 million adolescents and adults (15 years and older) 
across Europe and 172 million in north America could 
have a legacy of ACEs, with 142 million individuals in 
Europe and 103 million individuals in north America 
having experienced multiple ACEs. Each individual could 
carry ACE-related vulnerabilities to health-harming 
behaviours and, ultimately, NCDs. Global and national 
NCD plans need to be cognisant that ACEs contribute 
considerably to risk.
Even a modest 10% reduction in the prevalence of 
individuals with single or multiple ACEs in both regions 
could be equivalent to annual savings of $105 billion 
(3 million DALYs). Evidence-based approaches to prevent 
ACEs are available, including programmes to detect and 
support families at risk.44,45 For those experiencing ACEs, 
interventions to improve parenting skills, to strengthen 
parent–child attachment, and to develop children’s 
resilience can help to moderate the harmful effects of 
ACEs.46 However, advocacy for investment in such 
programmes rarely factors in the long-term benefits to 
mental health and NCD prevention. Consequently, they 
underestimate their potential return on investment and 
strategic appeal. Our results suggest that many conditions 
commonly seen in adults by health professionals are 
rooted in childhood. Trauma-informed health care47 can 
ensure such individuals receive support to address 
underlying drivers of health-harming behaviours and 
resultant NCDs. However, training on ACEs is rarely part 
of health-care and social-care curricula.
ACEs are relatively common events, even in the 
predominantly high-income and upper-middle-income 
countries included in this study. Additional ACE surveys 
are required to address the paucity of information on 
populations outside of north America and Europe. 
However, a growing body of research in low-income and 
middle-income countries (LMIC) already suggests that 
ACEs are more widespread in some parts of the world and 
show similar cumulative effects on health.9,48 Further 
research is required on what constitutes an ACE, 
particularly in LMICs where, for instance, millions of 
children are exposed to conflict, community-based 
violence, and other stressful experiences. Since margi- 
nalised communities in both high-income countries and 
LMICs often experience disproportionate numbers of 
ACEs, research is also required to ensure ACEs in such 
communities are fully represented in future estimates 
of the total health and economic burden of ACEs. A 
combination of ACE prevention, resilience building, and 
trauma-informed support could substantially reduce costs 
associated with ACEs. However, poor investment in 
interventions that provide safe and nurturing childhoods 
and help to deliver healthier, better educated, and more 
prosperous citizens represents short-termism in the 
thinking of governments and society at large. Such 
thinking might be costing around 3% of GDP, or 
considerably more if other ACE-related causes of ill health 
(such as violence), social issues (such as unemployment), 
and crime-related costs (such as imprisonment) are also 
factored in.
Our study has some limitations. The analysis was 
limited to risk factors and causes of ill health where 
suitable ACE studies had been done. Although these 
factors included many major risks to health and 
pressures on health-care systems, our estimates of ACE-
related DALYs and costs are incomplete. Further, 
inconsistency remains in the definitions and types of 
ACEs and health outcomes measured, study design, and 
methods of analysis. All such factors could affect the 
pooled estimates and associated heterogeneity. 
Heterogeneity varied considerably between regions, 
conditions, and extent of ACE exposure (table 2), and 
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more consistent studies are required to improve 
confidence in the types of population-level estimates that 
we calculated. However, although PAFs differed between 
north America and Europe, we found consistencies in 
the absolute value of some PAFs to ACEs (eg, for 
smoking) and the relative size of others (eg, higher PAFs 
for mental health conditions). ACE prevalence also 
varied between regions: prevalence was higher in north 
American populations, even when similar approaches 
were used with population samples. Previous work9 has 
identified a higher prevalence of violence against children 
in north America than in Europe. Although beyond the 
scope of this study, this finding might reflect societal 
differences in health, social care, and criminal justice 
environments.
The studies we included used binary measures of ACE 
exposure, which do not account for age and length of 
exposure. Such factors are likely to be important in refining 
relationships between ACEs and health over the life 
course. Categorisation of ACEs varied and so we were 
restricted to analysing in categories of zero, one, or two or 
more ACEs preventing more detailed examination of ACE 
counts and combinations. Standardisation of categorisation 
and other ACE analytical procedures would help to better 
elucidate dose-response relationships between ACEs, 
disease risk, and DALYs in future meta-analyses. Many 
studies were retrospective and self-reported, excluding 
individuals who had died (potentially from ACE-related 
conditions) and leaving participants subject to recall bias. 
Thus, additional prospective (as well as retrospective) ACE 
studies are an important consideration for further 
research. Depression might affect recall of ACEs although, 
generally, false-positive reports of ACEs appear rare.49 
Study inclusion was restricted to general populations and 
those not at high risk, but individuals unable to take part in 
general surveys (such as homeless people) are likely to 
have a high number of ACEs.50 Health outcomes were 
largely self-reported and study definitions were often 
absent or could not be matched to GBD categories. Further, 
overlap inevitably exists between DALYs for risk factors 
and causes. We accounted for this overlap by excluding 
risk factor DALYs captured in causes before calculating 
DALY totals. Although most studies controlled for age and 
socioeconomic groups, four studies22,28,35,36 did not account 
for both (table 1). We did not adjust our analysis for study 
quality, but one study35 consistently reported lower risk 
estimates. Where studies controlled for socioeconomic 
groups, we used adjusted risks. However, three studies20,28,31 
included a socioeconomic factor (eg, household living 
on public assistance) as an ACE. Poor consistency in 
how ACE-related risk measures are adjusted for 
socioeconomic groups is a limitation of ACE research and 
a likely source of heterogeneity. More standardisation of 
socioeconomic and ACE measurements would help to 
identify both the relationships each have with outcomes of 
interest and the relationships between ACEs and 
deprivation. Such understanding is crucial if policy is 
to appropriately address the relative contributions that 
poverty and ACEs make to poor life course health.
Sensitivity analyses generated a range of costs, but 
even the lower estimates represent substantive areas for 
potential savings through tackling ACEs and their con- 
sequences. Estimated costs are based on a broad 
assumption that a DALY might be considered equivalent 
to a year’s GDP per capita.15,41 This human capital model is 
likely to be conservative (by not fully accounting for pain 
and suffering) and more detailed economic modelling 
is required as better ACE-related data emerges. 
Finally, although measured where possible (appendix 
pp 8, 12, 16, 21) the potential effects of publication bias 
cannot be discounted.
ACEs were first described in the 1990s as a combined 
measure of childhood adversity.25 During the past two 
decades, this combined measure and related terminology 
have continued to develop, which might have affected 
what has been captured and included in this meta-
analysis. During the same period, ACE studies have 
increasingly provided a framework for examining the 
health effects of childhood trauma across the life course. 
Locally, findings from individual studies have been used 
to advocate for multi-agency actions and policies to 
prevent ACEs and support those suffering their 
consequences.51,52 Sadly, however, the effects of ACEs on 
national and international policy has been restricted. Our 
data from studies across Europe and north America 
show the huge personal and economic burden associated 
with children experiencing several ACEs. These burdens 
can be avoided if governments prioritise investment in 
children and fund evidence-based prevention strategies.53 
The eradication of child maltreatment is a reasonable 
goal for the 21st century. However, it requires an 
escalation of action to coordinate activities by health, 
social, judicial, educational, and other departments to 
collectively address child maltreatment, substance use, 
domestic violence, and other factors that deprive children 
of safe and nurturing childhoods. Arguably, such actions 
are justified simply from the perspective of protecting 
child rights. However, our results suggest that tackling 
ACEs will also reduce pressures from NCDs and mental 
illnesses on health systems, societal harms from alcohol 
and drug use, and contribute substantively to the 
economic development of nations.
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